PCOS treatment trial pits two common drugs Head-to-Head
NCT ID NCT07472179
Summary
This study compared two existing diabetes medications—pioglitazone and metformin—to see which works better for managing insulin resistance in women with Polycystic Ovary Syndrome (PCOS). Sixty women with PCOS and confirmed insulin resistance took one of the drugs daily for three months. Researchers measured changes in hormone levels, body measurements, and markers of insulin sensitivity to determine which treatment provided better control of PCOS symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PCOS(INSULIN RESISTANT) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bangladesh Medical University
Dhaka, Shahbag, 1000, Bangladesh
Conditions
Explore the condition pages connected to this study.